ArticleDrug safety2012

Cardiovascular, ocular and bone adverse reactions associated with thiazolidinediones: a disproportionality analysis of the US FDA adverse event reporting system database.

Domenico Motola et al.PubMed ↗Publisher ↗

No numbers read from the abstract.